Compare ASIC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASIC | IRMD |
|---|---|---|
| Founded | 2018 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2025 | 2014 |
| Metric | ASIC | IRMD |
|---|---|---|
| Price | $18.20 | $102.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $25.25 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 79.4K | 79.2K |
| Earning Date | 02-23-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | ★ 504.00 | 13.00 |
| EPS | 0.17 | ★ 1.65 |
| Revenue | ★ $405,657,000.00 | $80,511,268.00 |
| Revenue This Year | $14.87 | $15.17 |
| Revenue Next Year | $44.91 | $10.15 |
| P/E Ratio | $104.08 | ★ $61.82 |
| Revenue Growth | ★ 68.10 | 12.91 |
| 52 Week Low | $16.35 | $47.48 |
| 52 Week High | $25.30 | $103.06 |
| Indicator | ASIC | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.43 |
| Support Level | N/A | $96.67 |
| Resistance Level | N/A | $100.39 |
| Average True Range (ATR) | 0.00 | 2.31 |
| MACD | 0.00 | 0.13 |
| Stochastic Oscillator | 0.00 | 92.60 |
Ategrity Specialty Insurance Co Holdings Formerly Ategrity Specialty Holdings LLC is a specialty insurance company dedicated to providing excess and surplus products to small to medium-sized businesses across the United States. It offers property and casualty insurance solutions tailored to meet the needs of SMBs. The company focuses on are Real Estate, Hospitality, Construction, and Retail.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.